Antibiotic & Anti-Inflammatory Eye Drops Franchise in Ahmedabad

Neomycin + Fluorometholone Eye Drops Supplier in Mumbai

Ophthalmic Infection Care Distributor in Delhi

Steroid-Antibiotic Eye Drops Pharma Franchise in Bangalore

Neomycin Fluorometholone Eye Drops Stockist in Hyderabad
Ophthalmic Steroid-Antibiotic Eye Drop Manufacturer & Exporter in Chandigarh

Home/Products /neomycin-0-35-w-v-fluorometholone-0-1-w-v-eye-drop

Fluorise N Eye Drop

Composition : Neomycin (0.35% w/v) + Fluorometholone (0.1% w/v) Eye Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 10ml

Price : ₹1/-

Fluorise N Eye Drop contains Neomycin 0.35% w/v + Fluorometholone 0.1% w/v, a dual-action ophthalmic formulation designed to treat bacterial eye infections while reducing associated inflammation. Its combination ensures rapid infection control with steroidal symptom relief.

Neomycin works by inhibiting bacterial protein synthesis, effectively treating a broad spectrum of ocular bacterial pathogens, while Fluorometholone suppresses inflammatory mediators, reducing redness, swelling, and discomfort.

From a commercial perspective, Fluorise N Eye Drop is a high-prescription ophthalmic antibiotic-steroid combination, widely used in eye hospitals, clinics, and post-operative care, ensuring strong repeat prescriptions and consistent demand.

Including Fluorise N Eye Drop in your portfolio strengthens the ophthalmic steroid-antibiotic segment, offering long-term business growth, prescriber trust, and enhanced portfolio credibility for PCD pharma franchise partners.


Read More

About the Product

Fluorise N Eye Drop contains Neomycin 0.35% w/v + Fluorometholone 0.1% w/v, a dual-action ophthalmic formulation designed to treat bacterial eye infections while reducing associated inflammation. Its combination ensures rapid infection control with steroidal symptom relief.

Neomycin works by inhibiting bacterial protein synthesis, effectively treating a broad spectrum of ocular bacterial pathogens, while Fluorometholone suppresses inflammatory mediators, reducing redness, swelling, and discomfort.

From a commercial perspective, Fluorise N Eye Drop is a high-prescription ophthalmic antibiotic-steroid combination, widely used in eye hospitals, clinics, and post-operative care, ensuring strong repeat prescriptions and consistent demand.

Including Fluorise N Eye Drop in your portfolio strengthens the ophthalmic steroid-antibiotic segment, offering long-term business growth, prescriber trust, and enhanced portfolio credibility for PCD pharma franchise partners.


Common side effects may include mild burning or stinging sensation, temporary blurred vision, eye irritation, or dryness. Rarely, prolonged use may lead to increased intraocular pressure, cataract formation, secondary eye infections, or allergic reactions to Neomycin.

Fluorise N Eye Drop is indicated for the treatment of inflammatory ocular conditions where there is a risk or presence of bacterial infection, such as conjunctivitis, keratitis, or post-surgical eye inflammation. It should be used under the supervision of an ophthalmologist.

Use Fluorise N Eye Drop strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Do not use for prolonged periods without medical supervision. Discontinue and consult a doctor if severe irritation, vision changes, or signs of infection occur.

Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation